AI in Pancreatic Cancer
- [Rome, Italy - Civil Engineering Discoveries]
- Overview
Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of only 11%. The median overall survival for pancreatic cancer patients diagnosed with early screening was nearly 10 years, compared with 1.5 years for patients with pancreatic cancer not diagnosed with early screening.
Therefore, the early diagnosis and early treatment of pancreatic cancer is particularly critical. However, as a rare disease of pancreatic cancer, the general screening cost is high, the existing tumor markers are not accurate enough, and the therapeutic effect is not exact.
In terms of early diagnosis, artificial intelligence (AI) technology can quickly locate high-risk groups through medical imaging, pathological examinations, biomarkers, etc., and screen pancreatic cancer lesions at an early stage. At the same time, AI algorithms can also be used to predict survival time, recurrence risk, metastasis, and treatment response that may affect prognosis. In addition, artificial intelligence is widely used in pancreatic cancer health records, estimation of medical imaging
[More to come ...]
